戻る Agenda
Blockchain in Clinical Trials Demo: Truth or Dare
Session Chair(s)
Adama Ibrahim, MBA
Vice President, Digital Strategy and Change Management
Novo Nordisk, United Kingdom
Use blockchain to show the design and implementation of faster, less onerous user identification processes through permissioned access to a federated database pointing to a variety of traditionally siloed sources (inc. EMR, wearables, IoT etc).
Learning Objective : Describe how a blockchain-powered health wallet could support greater efficiencies across the clinical trial process.
Speaker(s)
Facilitator
Maria Palombini, MBA
IEEE-Standards Association, United States
Life Sciences Practice Lead, Global Business Strategy and Intelligence (GBSI)
Facilitator
Jim Nasr, MBA
ACOER and Ex-CDC, United States
Founder and Chief Executive Officer
Facilitator
Disa Lee Choun, MBA, RPH
Johnson & Johnson, United Kingdom
Head of Integrated Clinical & Operational Analytics
Blockchain
Mathew Rose, MD, MS, MSC
SAAVHA Inc., United States
Founder and Chief Executive Officer